78113-36-7CCCCCCCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@@H]([C@H](O)[C@H](O)CO)[C@H](C=O)NC(C)=O)C(N)=O)C(=O)OIKSJCVFYCIKDTB-GZZWOGMVSA-NRomurtide is a small molecule drug. Romurtide has a monoisotopic molecular weight of 886.56 Da.
78113-36-7DTXSID401318575CHEMBL1908331Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 40 reports by companies from 2 notifications to the ECHA C&L Inventory.
Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity.
BeschreibungRomurtide is a muramyl dipeptide which augments the production of G-CSF. The compound is indicated as an immunomodulator for the treatment of leukopenia caused by anticancer chemotherapy/radiotherapy and also thrombopenia.
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Wird geladen…